TATVA — Tatva Chintan Pharma Chem Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹27.78bn
- IN₹28.89bn
- IN₹5.06bn
Annual cashflow statement for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,041 | 448 | 436 | 75.8 | 570 |
| Depreciation | |||||
| Non-Cash Items | 17.8 | 112 | 30 | 16.5 | 72.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -937 | -377 | 259 | -122 | -696 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 204 | 278 | 980 | 247 | 315 |
| Capital Expenditures | -892 | -2,031 | -1,285 | -763 | -1,138 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,076 | 1,020 | 79.8 | 110 | -20.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,968 | -1,011 | -1,205 | -653 | -1,158 |
| Financing Cash Flow Items | 2,032 | -128 | 1,841 | -12.9 | -27.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,350 | 378 | 305 | 166 | 789 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 585 | -357 | 79.4 | -239 | -56.1 |